Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in antisense therapeutics, today announced that management will present a company overview at the following virtual investor conferences:...

Phosplatin Therapeutics, a clinical stage pharmaceutical company focused on oncology therapeutics, today announced that new clinical data from a dose escalation study (NCT 03409458) of lead...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the presentation of new, positive data for the PD-1 inhibitor Libtayo® (cemiplimab) at the European Society for Medical...

Charter Communications, Inc. (NASDAQ: CHTR) (along with its subsidiaries, "Charter") today announced that Christopher Winfrey, Chief Financial Officer, will participate in the Bank of America 2020...